Mafirakureva N, Paruk F, Cassim B, Lukhele M, Gregson C L, Noble S M
Health Economic and Decision Science, School of Health and Related Research, University of Sheffield, Sheffield, UK.
Musculoskeletal Research Unit, Translational Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Osteoporos Int. 2023 Apr;34(4):803-813. doi: 10.1007/s00198-022-06664-9. Epub 2023 Jan 27.
Despite rapidly ageing populations, data on healthcare costs associated with hip fracture in Sub-Saharan Africa are limited. We estimated high direct medical costs for managing hip fracture within the public healthcare system in SA. These findings should support policy decisions on budgeting and planning of hip fracture services.
We estimated direct healthcare costs of hip fracture (HF) management in the South African (SA) public healthcare system.
We conducted a micro-costing study to estimate costs per patient treated for HF in five regional public sector hospitals in KwaZulu-Natal (KZN), SA. Two hundred consecutive, consenting patients presenting with a fragility HF were prospectively enrolled. Resources used including staff time, consumables, laboratory investigations, radiographs, operating theatre time, surgical implants, medicines, and inpatient days were collected from presentation to discharge. Counts of resources used were multiplied by unit costs, estimated from the KZN Department of Health hospital fees manual 2019/2020, in local currency (South African Rand, ZAR), and converted to 2020 US$ prices. Generalized linear models estimated total covariate-adjusted costs and cost predictors.
The mean unadjusted cost for HF management was US$6935 (95% CI; US$6401-7620) [ZAR114,179 (95% CI; ZAR105,468-125,335)]. The major cost driver was orthopaedics/surgical ward costs US$5904 (95% CI; 5408-6535), contributing to 85% of total cost. The covariate-adjusted cost for HF management was US$6922 (95% CI; US$6743-7118) [ZAR113,976 (95% CI; ZAR111,031-117,197)]. After covariate adjustment, total costs were higher in patients operated under general anaesthesia [US$7251 (95% CI; US$6506-7901)] compared to surgery under spinal anaesthesia US$6880 (95% CI; US$6685-7092) and no surgery US$7032 (95% CI; US$6454-7651).
Healthcare costs following a HF are high relative to the gross domestic product per capita and per capita spending on health in SA. As the population ages, this significant economic burden to the health system will increase.
尽管撒哈拉以南非洲地区人口迅速老龄化,但该地区与髋部骨折相关的医疗费用数据有限。我们估计了南非公共医疗系统中髋部骨折管理的高昂直接医疗费用。这些发现应有助于为髋部骨折服务的预算和规划提供政策决策依据。
我们估计了南非公共医疗系统中髋部骨折(HF)管理的直接医疗费用。
我们进行了一项微观成本研究,以估计南非夸祖鲁-纳塔尔省(KZN)五家地区公立医院中每位接受HF治疗的患者的费用。前瞻性纳入了200例连续的、同意参与的脆性HF患者。收集从就诊到出院所使用的资源,包括工作人员时间、耗材、实验室检查、X光片、手术室时间、手术植入物、药品和住院天数。所使用资源的数量乘以根据KZN卫生部2019/2020年医院收费手册估算的单位成本,以当地货币(南非兰特,ZAR)计算,并转换为2020年美元价格。广义线性模型估计了总协变量调整成本和成本预测因素。
HF管理的平均未调整成本为6935美元(95%置信区间;6401 - 7620美元)[114,179兰特(95%置信区间;105,468 - 125,335兰特)]。主要成本驱动因素是骨科/外科病房成本5904美元(95%置信区间;5408 - 6535美元),占总成本的85%。HF管理的协变量调整成本为6922美元(95%置信区间;6743 - 7118美元)[113,976兰特(95%置信区间;111,031 - 117,197兰特)]。协变量调整后,全身麻醉下手术的患者总成本[7251美元(95%置信区间;6506 - 7901美元)]高于脊髓麻醉下手术的患者[6880美元(95%置信区间;6685 - 7092美元)]和未手术的患者[7032美元(95%置信区间;6454 - 7651美元)]。
相对于南非的人均国内生产总值和人均卫生支出,髋部骨折后的医疗费用较高。随着人口老龄化,这对卫生系统的巨大经济负担将会增加。